Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

Osteoid Osteoma Clinical Trial

Official title:
Phase III Study to Compare the Effectiveness of Magnetic Resonance Guided Focused Ultrasound With Computed Tomography Guided Radiofrequency Ablation for Treatment of Osteoid Osteomas

Status Recruiting

Clinical Trial Summary

Osteoid osteomas are painful, benign bone tumors that occur most frequently in young males between ages 10 and 20 years. The goal of the proposed study is based on the premise that MRgFUS is noninferior to CT-guided radiofrequency ablation (CTgRFA), in terms of pain reduction following treatment of osteoid osteomas, and offers possible improvements with regards to 1) post-procedural pain, 2) clinical resource utilization, 3) patient experience, and/or 4) adverse events. The data from the current study would provide clinicians important information in deciding between treatment options for ablation of osteoid osteomas.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02923011
Study type	Interventional
Source	University of California, San Francisco
Contact	Maya Aslam
Email	maya.aslam@ucsf.edu
Status	Recruiting
Phase	Phase 3
Start date	March 28, 2017
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02739555` - Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma	Phase 3
Active, not recruiting	`NCT04658771` - MR-HIFU Treatment of Painful Osteoid Osteoma	Phase 2
Completed	`NCT02349971` - Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children	N/A
Completed	`NCT01466010` - Treatment Outcome After Surgical Treatment of Osteoid Osteoma	N/A
Completed	`NCT02618369` - MR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and Adults	N/A